Ms. Daniela Bosshardt-Hengartner is a Chairman at Galenica AG.
She is on the Board of Directors at RepRisk AG and Stiftung Avenir Suisse.
She works as an independent consultant in the area of financial analysis and business development for investment managers and corporates.
She is a member of the Board of Directors of Galenica, a diversified healthcare firm.
She previously served as a member of the Board of Directors of Nobel Biocare and La-Joux Perret SA. Prior to this, she was a financial analyst at the Bank am Bellevue and at M2 Capital.
She also served as the Chief Financial Officer (CFO) of Bellevue Asset Management.
She holds a Swiss Federal Diploma in Pharmacy from the Swiss Federal Institute of Technology (ETH) in Zurich, Switzerland.